Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. Issue 1 (2nd January 2021)
- Record Type:
- Journal Article
- Title:
- Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. Issue 1 (2nd January 2021)
- Main Title:
- Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index
- Authors:
- Mohamed, AA
Omran, D
El-Feky, S
Darwish, H
Kassas, AEL
Farouk, A
Ezzat, O
Abdo, SM
Zahran, FE
El-Demery, A
Omran, MM - Abstract:
- ABSTRACT: Background: Hepatitis B and C viruses are leading causes of liver cirrhosis and hepatocellular carcinoma (HCC). Toll-like receptor 7 (TLR-7) has been implicated in the pathogenesis of HCC linked to hepatitis B. We hypothesised a role of leukocyte TLR-7 mRNA in hepatitis C related liver cirrhosis and HCC, using alpha-fetoprotein (AFP) and liver function tests as comparators. Methods: We recruited 102 patients with HCV-related HCC, 97 with HCV-related liver cirrhosis and 60 healthy controls. Quantification of TLR-7 mRNA was performed using real-time PCR, AFP and routine LFTs by standard techniques. Results: TLR-7 mRNA levels were significantly lower in HCC patients compared to cirrhotic patients and lower again in healthy controls (p < 0.001 for trend). In multivariate analysis, age, aspartate transaminase (AST), AFP, and TLR-7 mRNA were significant predictors of HCC. The ROCC/AUC for age, AST and TLR-7 mRNA were all between 0.64 and 0.78 (all P < 0.01), but for AFP was 0.57 (95% CI 0.48–0.65, P = 0.09). We derived an index score using age, AST and TLR-7 mRNA for the diagnosis of HCC. The ROCC/AUC for the index was superior to all three root indices in the prediction of HCC. The index linked significantly with the Tokyo and Vienna liver cancer staging systems, but not with those of the CLIP and Okuda systems, in distinguishing HCC from liver cirrhosis. Conclusion: The combination of TLR-7 mRNA levels with age and AST improves the performance of TLR-7 in HCCABSTRACT: Background: Hepatitis B and C viruses are leading causes of liver cirrhosis and hepatocellular carcinoma (HCC). Toll-like receptor 7 (TLR-7) has been implicated in the pathogenesis of HCC linked to hepatitis B. We hypothesised a role of leukocyte TLR-7 mRNA in hepatitis C related liver cirrhosis and HCC, using alpha-fetoprotein (AFP) and liver function tests as comparators. Methods: We recruited 102 patients with HCV-related HCC, 97 with HCV-related liver cirrhosis and 60 healthy controls. Quantification of TLR-7 mRNA was performed using real-time PCR, AFP and routine LFTs by standard techniques. Results: TLR-7 mRNA levels were significantly lower in HCC patients compared to cirrhotic patients and lower again in healthy controls (p < 0.001 for trend). In multivariate analysis, age, aspartate transaminase (AST), AFP, and TLR-7 mRNA were significant predictors of HCC. The ROCC/AUC for age, AST and TLR-7 mRNA were all between 0.64 and 0.78 (all P < 0.01), but for AFP was 0.57 (95% CI 0.48–0.65, P = 0.09). We derived an index score using age, AST and TLR-7 mRNA for the diagnosis of HCC. The ROCC/AUC for the index was superior to all three root indices in the prediction of HCC. The index linked significantly with the Tokyo and Vienna liver cancer staging systems, but not with those of the CLIP and Okuda systems, in distinguishing HCC from liver cirrhosis. Conclusion: The combination of TLR-7 mRNA levels with age and AST improves the performance of TLR-7 in HCC diagnosis, out-performs alpha-fetoprotein and predicts early HCC. … (more)
- Is Part Of:
- British journal of biomedical science. Volume 78:Issue 1(2021)
- Journal:
- British journal of biomedical science
- Issue:
- Volume 78:Issue 1(2021)
- Issue Display:
- Volume 78, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 78
- Issue:
- 1
- Issue Sort Value:
- 2021-0078-0001-0000
- Page Start:
- 18
- Page End:
- 22
- Publication Date:
- 2021-01-02
- Subjects:
- Liver cancer -- diagnosis -- Toll-like receptor-7 -- index
Medical sciences -- Periodicals
Medical technology -- Periodicals
Biological Science Disciplines
Clinical Laboratory Techniques
Medical Laboratory Science
Anatomie pathologique
Medical sciences
Medical technology
Klinische chemie
Laboratoriumonderzoek
Periodicals
Periodicals
616.0756
610.07 M489L - Journal URLs:
- http://catalog.hathitrust.org/api/volumes/oclc/27845663.html ↗
http://www.ibms.org/index.cfm?method=publications.british_journal ↗
http://www.tandfonline.com/loi/tbbs20?open=67&repitition=0 ↗
https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science ↗ - DOI:
- 10.1080/09674845.2020.1778842 ↗
- Languages:
- English
- ISSNs:
- 0967-4845
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2306.730000
British Library HMNTS - ELD Digital store - Ingest File:
- 22708.xml